Article Cited by others


Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases

Ventrice Pasquale, Leporini Christian, Aloe Jose«SQ» Francisco, Greco Ettore, Leuzzi Giacomo, Marrazzo Giuseppina, Scorcia Giovanni Battista, Bruzzichesi Donatella, Nicola Varano, Scorcia Vincenzo

Year : 2013| Volume: 4| Issue : 5 | Page no: 38-42

   This article has been cited by
1 SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform
John M. Hatcher,Guowei Wu,Chuyue Zeng,Jie Zhu,Fan Meng,Sherrina Patel,Wenqiu Wang,Scott B. Ficarro,Alan L. Leggett,Chelsea E. Powell,Jarrod A. Marto,Kang Zhang,Jacky Chi Ki Ngo,Xiang-Dong Fu,Tinghu Zhang,Nathanael S. Gray
Cell Chemical Biology. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies
Saima Subhani,Divya Teja Vavilala,Mridul Mukherji
Angiogenesis. 2016; 19(3): 257
[Pubmed]  [Google Scholar] [DOI]
3 12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1a in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway
Ying Yang,Huan Cong,Cuicui Han,Liling Yue,Haiying Dong,Jicheng Liu
Oncology Reports. 2015;
[Pubmed]  [Google Scholar] [DOI]
4 Successful long-term management of choroidal neovascularization secondary to angioid streaks in a patient with pseudoxanthoma elasticum: a case report
Maria Savastano,Angelo Minnella,Gaetano Zinzanella,Benedetto Falsini,Aldo Caporossi
Journal of Medical Case Reports. 2014; 8(1): 458
[Pubmed]  [Google Scholar] [DOI]
5 Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse
Silvia Maestroni,Anna Maestroni,Simona Ceglia,Gemma Tremolada,Monica Mancino,Angelina Sacchi,Rosangela Lattanzio,Ilaria Zucchiatti,Angelo Corti,Francesco Bandello,Gianpaolo Zerbini
Acta Ophthalmologica. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]


Read this article